Maastricht, 23 December 2021 – RegMed XB has received the first subsidy of 23 million euros from the Ministry of Economic Affairs and Climate Policy. This is the start of the realization of the national pilot factory for regenerative medicine after the Dutch cabinet decided on 9 April this year to fund the National Growth Fund proposal of RegMed XB.

Leiden University Medical Centre (LUMC), the DanStem Institute at the University of Copenhagen and the Murdoch Children's Research Institute in Melbourne will jointly receive 300 million euros from the Novo Nordisk Foundation. 

Jasia King, Silvia M. Mihaila, Sabbir Ahmed, Roman Truckenmüller, Stefan Giselbrecht, Rosalinde Masereeuw and Aurélie Carlier from MERLN Institute for Technology-Inspires Medicine, Maastricht University and Division of Pharmacology.